Dispenzieri, Angela
Arendt, Bonnie
Dasari, Surendra
Kohlhagen, Mindy
Kourelis, Taxiarchis
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Buadi, Francis K.
Warsame, Rahma
Kyle, Robert A.
Lacy, Martha Q.
Dingli, David
Kapoor, Prashant
Gonsalves, Wilson I.
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Hayman, Suzanne R.
Hwa, Yi Lisa
Fonder, Amy
Hobbs, Miriam
Jevremovic, Dragan
Lust, John A.
Zeldenrust, Steven
Russell, Steve J.
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Gertz, Morie A.
Murray, David
Article History
Received: 2 August 2019
Revised: 28 January 2020
Accepted: 13 February 2020
First Online: 25 February 2020
Conflict of interest
: A.D.: Research funding (Celgene, Millennium, Pfizer, Alnylam), Travel grant (Pfizer); Consultancy (Intellia, Akcea, and Janssen); B.A.: no disclosure; S.D., Ph.D., has patent rights on the assay. M.K.: None. Taxiarchis vs. Kourelis: None; S.K.K.: Consultancy (Celgene, Millennium, Onyx, Janssen, and BMS); and research funding (Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS); N.L.: None; E.M.: None; F.K.B.: None; R.W.: None; R.A.K.: None; M.Q.L.: Research funding (Celgene); D.D.: Research funding (Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals); P.K.: Research funding (Takeda, Celgene, and Amgen); W.I.G.: None; R.S.G.: None; S.R.H.: None; Y.L.H.: None; A.F.: None; M.H.: None; D.J.: None; J.A.L.: None; Yi Lin: None; S.Z.: None; S.J.R.: None; V.S.R.: None; M.A.G.: Consultancy (Milleniu) and honoraria (Celgene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis); D.M. has patent rights on the assay and has received research support from the Binding Site Ltd.